These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 9950442

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Which index of peak expiratory flow is most useful in the management of stable asthma?
    Reddel HK, Salome CM, Peat JK, Woolcock AJ.
    Am J Respir Crit Care Med; 1995 May; 151(5):1320-5. PubMed ID: 7735580
    [Abstract] [Full Text] [Related]

  • 3. Variability of peak expiratory flow rate in allergic rhinitis and mild asthma: relationship to maximal airway narrowing.
    Prieto L, Gutiérrez V, Morales C, Perpiñan J, Inchaurraga I.
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):151-8. PubMed ID: 9494447
    [Abstract] [Full Text] [Related]

  • 4. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.
    Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O'Byrne PM, Löfdahl CG, Pauwels RA, Ullman A.
    Am J Respir Crit Care Med; 1999 Aug; 160(2):594-9. PubMed ID: 10430734
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Study of personal best value of peak expiratory flow in patients with asthma--comparison of the highest value of daily PEF under good control and the highest value of daily PEF obtained after using repeated inhaled beta2-agonist during high-dose inhaled steroid treatment].
    Watanabe N, Makino S, Kihara N, Fukuda T.
    Arerugi; 2008 Dec; 57(12):1284-92. PubMed ID: 19169083
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics.
    Weersink EJ, van Zomeren EH, Koëter GH, Postma DS.
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1144-50. PubMed ID: 9351614
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma.
    Zimmerman B, D'Urzo A, Bérubé D.
    Pediatr Pulmonol; 2004 Feb; 37(2):122-7. PubMed ID: 14730657
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. When can personal best peak flow be determined for asthma action plans?
    Reddel HK, Marks GB, Jenkins CR.
    Thorax; 2004 Nov; 59(11):922-4. PubMed ID: 15516464
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.